Research

One Hour PCC Study

UCSF Phone Study

One Hour PCC Study

One Hour PCC Study

About Us

We are a team of trainers and researchers, led by James Dilley, MD, the Principal Investigator of the several studies about Personal Cognitive Counseling (PCC), a brief HIV risk reduction intervention. The team also includes Tim Allen and Peter Loeb, co-authors and designers of the original PCC manual and counselor training, and Martha Shumway, Ph.D., a mental health researcher at UCSF. This project is supported by the National Institute of Mental Health, grant number 2 R44 MH099917, and conducted by Allen/Loeb Associates in collaboration with the Alliance Health Project in the UCSF Department of Psychiatry.

About the Study

This study is part of a larger project evaluating web-based training in the evidence-based HIV prevention intervention Personalized Cognitive Counseling (PCC).

This study compares the usability and immediate impact of text and video strategies for web-based training in health risk reduction interventions for health and mental health professionals. The results will give us information about which kinds of training work best and will help us incorporate the feedback of health and mental health care professionals.

Who Can Participate?

Anyone who is a health or mental health care professional, or is in training to become a health or mental health care professional, is at least 18 years old, and has access to a computer, smartphone, or tablet can take part in this study. People who have already been trained to deliver Personalized Cognitive Counseling are not eligible to take part in the study.

What Does Participation Involve?

Participation takes about an hour and involves:

  1.  completing a brief on-line eligibility questionnaire;
  2.  spending about 45 minutes on the Internet viewing information about how to talk to clients about risky health behaviors (in the context of HIV           prevention);
  3.  spending about 15 minutes completing an online survey.

Participants who complete the online survey after viewing the information will receive a $40 Amazon electronic gift card.

Interested in Participating?

Go to https://is.gd/PCCStudy to complete the eligibility questionnaire.

Have Questions?

E-mail us at [email protected] or

Call us at 833/PCC-SUPP (833/722-7877)

 

UCSF Phone Study

Our team at UCSF is doing a study of confidential, non-judgmental counseling delivered over the telephone. The counseling session is called Personalized Cognitive Counseling—PCC for short. When the session is done on the phone, it’s called TelePCC. If you agree to be in this study, you will participate in a TelePCC session on your phone.

More About the Phone Study
Participating in the study involves a phone conversation with a counselor that lasts up to 40 minutes: 10 minutes to explain the study and ask for your consent and 30 minutes to talk about a recent time you had unprotected sex.

If you participate, you will complete 2 web-based surveys—one right after the call, and one 3 months later. Each survey takes about 20 minutes. You’ll be paid $20 for completing the first survey and $40 for the second. You can also take part in a phone interview to tell us about your experience and be paid another $30. (The total payment for completing all three steps is $90). You can withdraw from the study at any time.

You can be in the study if you are:
age 18 or older
a man who has sex with men
have not tested positive for HIV
have had anal intercourse with a male who you weren’t sure was negative, while unprotected by a condom or PrEP.

If you are interested in participating in the study:
Call 833-TELEPCC (833-835-3722) at one of these times:

Monday 5pm–7pm
Tuesday 5pm–7pm
Wednesday 1pm–3pm
Thursday 9:30am–11:30 am

Please call when you have about 40 minutes of free time and can talk in a private place without being overheard.

The project is supported by the National Institute of Mental Health and is conducted by University of California, San Francisco with Allen/Loeb Associates. UCSF Principal Investigator: James W. Dilley, MD.